Prognostic impact of deficient DNA mismatch repair in patients with stage III colon cancer from a randomized trial of FOLFOX-based adjuvant chemotherapy.
暂无分享,去创建一个
D. Sargent | S. Thibodeau | M. Bertagnolli | R. Goldberg | T. Smyrk | S. Alberts | M. Mahoney | F. Sinicrope | R. Warren | G. Nelson